Expertise in
14
conditions

Grainne S. Gorman

The Medical School Framlington Place, 
Newcastle Upon Tyne, ENG, GB 
Expertise in
14
conditions
The Medical School Framlington Place, 
Newcastle Upon Tyne, ENG, GB 

Overview

Grainne Gorman practices practicing medicine in Newcastle Upon Tyne, United Kingdom.

Ms. Gorman is highly rated in 14 conditions, according to our data. Her clinical expertise encompasses MELAS Syndrome, Progressive External Ophthalmoplegia, Paramyotonia Congenita, and Myotonic Dystrophy Type 2.

She is actively involved in clinical research, co-authoring 148 peer reviewed articles and participating in 2 clinical trials.

Gender

Female

Locations

The Medical School Framlington Place, Newcastle Upon Tyne, ENG, United Kingdom
Other Locations
1501 North Campbell Avenue, Tucson, AZ 85724

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Randomized, Double-Blind Study to Evaluate the Efficacy and Safety of Tideglusib Versus Placebo for the Treatment of Children and Adolescents With Congenital Myotonic Dystrophy (REACH CDM)
A Randomized, Double-Blind Study to Evaluate the Efficacy and Safety of Tideglusib Versus Placebo for the Treatment of Children and Adolescents With Congenital Myotonic Dystrophy (REACH CDM)
Enrollment Status: Completed
Publish Date: October 08, 2025
Intervention Type: Drug
Study Drug: Tideglusib
Study Phase: Phase 2/Phase 3
An Open-label Study to Evaluate the Safety and Tolerability of 12 Weeks Treatment With Oral REN001 in Patients With Primary Mitochondrial Myopathy (PMM), With an Optional Extension of Treatment
An Open-label Study to Evaluate the Safety and Tolerability of 12 Weeks Treatment With Oral REN001 in Patients With Primary Mitochondrial Myopathy (PMM), With an Optional Extension of Treatment
Enrollment Status: Terminated
Publish Date: July 16, 2020
Intervention Type: Drug
Study Phase: Phase 1
View 1 Less Clinical Trial

147 Total Publications

Mavodelpar in patients with primary mitochondrial myopathy: a phase 1 trial.
Mavodelpar in patients with primary mitochondrial myopathy: a phase 1 trial.
Journal: Scientific reports
Published: December 11, 2025

Frequently Asked Questions about Grainne S. Gorman

Is Grainne S. Gorman a top-rated expert for MELAS Syndrome?

MediFind is an objective health platform that identifies experts based on real-world data. Grainne S. Gorman is classified as an Distinguished expert for MELAS Syndrome, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Grainne S. Gorman participate in research or clinical trials?

Yes. Grainne S. Gorman has published 147 articles and abstracts on conditions like MELAS Syndrome. You can view a list of Grainne S. Gorman's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Gorman's expertise for a condition
ConditionClose
    View All 9 Advanced Conditions
    View All 33 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile